The efficacy of cytostatic therapy for malignant tumors as determined by x-rays
Zwicker, H.; Gürtler, J.
Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 29(8): 365-373
1976
ISSN/ISBN: 0300-8592 PMID: 785582 Document Number: 98688
Cytostatic or hormone therapy for malignant tumors has made some progress during the last few years. Total or, at least, extensive recession of bronchial carcinoma, metastasizing breast tumors and lymphogranulomatosis in Stage IV as the result of chemotherapy or hormone therapy was presented which was substantiated by x-rays.
Document emailed within 1 workday
Related Documents
Marek, K. 1972: Trial of cytostatic therapy of malignant brain tumors in adults Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 110(1): 27-43Quäck, J. 1973: Cytostatic therapy of malignant tumors from radiological point of view Die Medizinische Welt 24(47): 1845-1848
Hymmen, U.; Wieland, C. 1979: Combined treatment of radioresistant malignant tumors with high frequency hyperthermia and gamma-rays therapy--recent results Journal of Microwave Power 14(2): 173-180
Stepankovskaia, G.K.; Milianovskiĭ, A.I.; Frolova, G.D. 1977: Determination of sensitivity to cytostatic preparations during chemotherapy of malignant tumors Vrachebnoe Delo 2: 109-112
Rob, L.; Svoboda, B.; Robová, H.; Stankusová, H.; Cwiertka, K.; Neumannová, R.; Petera, J.; Koliba, P.; Kudela, M. 2004: Guideline for gynecological malignant tumors--primary complex therapy in operable stages of malignant tumors of uterus cervix Ceska Gynekologie 69(5): 376-383
Král, V.; Hajdúch, M.; Neoral, C.; Klein, J.; Mihál, V.; Orel, M.; Aujeský, R.; Vyslouzil, K.; Cwiertka, K.; Kolek, V.; Nosková, V. 2000: Significance and possibilities of cytostatic treatment of malignant tumors: testing the effects of cytostatics Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 79(3): 134-138
Höffken, K.; Schmidt, C.G. 1986: Cytostatic drugs in the therapy of gastrointestinal tumors Medizinische Klinik 81(4): 135-141
Diadyk, A.I.; Vasilenko, I.V.; Siniachenko, O.V.; Iarovaia, N.F.; Shpilevaia, N.I.; Bagriĭ, A.E.; Khomenko, M.V.; Chernykh, O.S.; Efremenko, V.A.; Zviagina, T.V. 1992: The efficacy of the glucocorticoid and cytostatic therapy of lupus glomerulonephritis Terapevticheskii Arkhiv 64(10): 111-114
Von Gumppenberg, S.; Fink, U.; Lindner, H. 1978: Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors Fortschritte der Medizin 96(31): 1542-1549
Trashkov, A.P.; Vasil'ev, A.G.; Kovalenko, A.L.; Petrov, A.Y.; Valeev, V.V. 2016: Influence of Angioprotector Drugs on the Efficacy of Cytostatic Therapy (Experimental Study) Eksperimental'naia i Klinicheskaia Farmakologiia 79(2): 34-39
Varmas, K.D.; Schenck, P.; Lange, D. 1971: A study of simultaneous radioactive gold and cytostatic therapy in the treatment of malignant effusions Nuclear-Medizin 10(1): 69-76
Hansen, S.H.; Vetner, M. 1974: Fatal varicella infection in two patients with malignant systemic disease in cytostatic therapy Ugeskrift for Laeger 136(26): 1451
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Ogilvie, G.K.; Moore, A.S.; Obradovich, J.E.; Elmslie, R.E.; Vail, D.M.; Straw, R.C.; Salmon, M.D.; Klein, M.K.; Atwater, S.W.; Ciekot, P.E. 1993: Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors Journal of the American Veterinary Medical Association 202(11): 1839-1844
Vyslouzil, K.; Klementa, I.; Bednarík, J. 1996: Therapy of malignant tumors of the rectum--the extent and significance of radical surgical therapy Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 75(11): 517-520
Tamiya, T.; Ohmoto, T.; Wei, M.X.; Breakfield, X.O.; Chiocca, E.A. 1994: Gene therapy for brain tumors: gene therapy for malignant brain tumors using prodrug-sensitivity genes (series 4) No Shinkei Geka. Neurological Surgery 22(12): 1099-1110
Velikaya, V.V.; Gribova, O.V.; Musabaeva, L.I.; Startseva, Z.A.; Simonov, K.A.; Aleinik, A.N.; Lisin, V.A. 2015: Ozone therapy for radiation reactions and skin lesions after neutron therapy in patients with malignant tumors Voprosy Onkologii 61(4): 571-574
Panpikoon, T.; Treesit, T.; Thapaneeyakorn, J.; Wedsart, B.; Inman, T. 2013: Efficacy of percutaneous radiofrequency ablation of hepatic malignant tumors using a perfused-cooled electrode Journal of the Medical Association of Thailand 96(1): 77-82
Mäsiar, P.; Jakes, F.; Medeková, E. 1983: Diagnosis of malignant tumors. V. Metabolites of biomacromolecules (proteins and nucleic acids) in the serum and urine of the host of a malignant teratoma of the testis. Significance for diagnosis, therapy and prognosis Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 62(5): 375-384